Effect of Behavioral and Pelvic Floor Muscle Therapy Combined With Surgery vs Surgery Alone on Incontinence Symptoms Among Women With Mixed Urinary Incontinence: The ESTEEM Randomized Clinical Trial.


Journal

JAMA
ISSN: 1538-3598
Titre abrégé: JAMA
Pays: United States
ID NLM: 7501160

Informations de publication

Date de publication:
17 09 2019
Historique:
entrez: 19 9 2019
pubmed: 19 9 2019
medline: 24 9 2019
Statut: ppublish

Résumé

Mixed urinary incontinence, including both stress and urgency incontinence, has adverse effects on a woman's quality of life. Studies evaluating treatments to simultaneously improve both components are lacking. To determine whether combining behavioral and pelvic floor muscle therapy with midurethral sling is more effective than sling alone for improving mixed urinary incontinence symptoms. Randomized clinical trial involving women 21 years or older with moderate or severe stress and urgency urinary incontinence symptoms for at least 3 months, and at least 1 stress and 1 urgency incontinence episode on a 3-day bladder diary. The trial was conducted across 9 sites in the United States, enrollment between October 2013 and April 2016; final follow-up October 2017. Behavioral and pelvic floor muscle therapy (included 1 preoperative and 5 postoperative sessions through 6 months) combined with midurethral sling (n = 209) vs sling alone (n = 207). The primary outcome was change between baseline and 12 months in mixed incontinence symptoms measured by the Urogenital Distress Inventory (UDI) long form; range, 0 to 300 points; minimal clinically important difference, 35 points, with higher scores indicating worse symptoms. Among 480 women randomized (mean [SD] age, 54.0 years [10.7]), 464 were eligible and 416 (86.7%) had postbaseline outcome data and were included in primary analyses. The UDI score in the combined group significantly decreased from 178.0 points at baseline to 30.7 points at 12 months, adjusted mean change -128.1 points (95% CI, -146.5 to -109.8). The UDI score in the sling-only group significantly decreased from 176.8 to 34.5 points, adjusted mean change -114.7 points (95% CI, -133.3 to -96.2). The model-estimated between-group difference (-13.4 points; 95% CI, -25.9 to -1.0; P = .04) did not meet the minimal clinically important difference threshold. Related and unrelated serious adverse events occurred in 10.2% of the participants (8.7% combined and 11.8% sling only). Among women with mixed urinary incontinence, behavioral and pelvic floor muscle therapy combined with midurethral sling surgery compared with surgery alone resulted in a small statistically significant difference in urinary incontinence symptoms at 12 months that did not meet the prespecified threshold for clinical importance. ClinicalTrials.gov Identifier: NCT01959347.

Identifiants

pubmed: 31529007
pii: 2749872
doi: 10.1001/jama.2019.12467
pmc: PMC6749544
doi:

Banques de données

ClinicalTrials.gov
['NCT01959347']

Types de publication

Comparative Study Equivalence Trial Journal Article Multicenter Study Randomized Controlled Trial Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1066-1076

Subventions

Organisme : NICHD NIH HHS
ID : U10 HD054215
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD069025
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD069013
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD041261
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD069010
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD041267
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD054214
Pays : United States
Organisme : NICHD NIH HHS
ID : U01 HD069031
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD069006
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD069006
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD069010
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD069013
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD041261
Pays : United States
Organisme : NICHD NIH HHS
ID : U24 HD069031
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Références

BJU Int. 2007 Jul;100(1):76-81
pubmed: 17433028
Cochrane Database Syst Rev. 2017 Jul 31;7:CD006375
pubmed: 28756647
Qual Life Res. 2005 Apr;14(3):849-55
pubmed: 16022077
Am J Obstet Gynecol. 2011 Aug;205(2):150.e1-6
pubmed: 21640964
Obstet Gynecol. 2008 Mar;111(3):611-21
pubmed: 18310363
JAMA. 2014 Mar 12;311(10):1023-34
pubmed: 24618964
JAMA. 2011 Jan 12;305(2):151-9
pubmed: 21224456
J Urol. 2006 Aug;176(2):627-32; discussion 632
pubmed: 16813906
Female Pelvic Med Reconstr Surg. 2017 May/Jun;23(3):177-178
pubmed: 28441276
J Urol. 2017 Oct;198(4):875-883
pubmed: 28625508
Neurourol Urodyn. 2009;28(5):416-22
pubmed: 19030182
Int Urogynecol J. 2017 May;28(5):687-696
pubmed: 28321473
Neurourol Urodyn. 2018 Jan;37(1):14-26
pubmed: 28464426
Int Urogynecol J. 2016 Oct;27(10):1479-90
pubmed: 27287818
Am J Obstet Gynecol. 2009 May;200(5):580.e1-7
pubmed: 19375574
Aust N Z J Obstet Gynaecol. 2005 Aug;45(4):300-3
pubmed: 16029296
JAMA. 2014 May 21;311(19):2007-14
pubmed: 24846038
Qual Life Res. 1994 Oct;3(5):291-306
pubmed: 7841963
Curr Opin Urol. 2005 Nov;15(6):374-9
pubmed: 16205486
Neurourol Urodyn. 2009;28(4):268-73
pubmed: 19274758
N Engl J Med. 2010 Jun 3;362(22):2066-76
pubmed: 20479459
Int Urogynecol J Pelvic Floor Dysfunct. 2008 May;19(5):655-63
pubmed: 18183344
N Engl J Med. 2016 Sep 1;375(9):861-70
pubmed: 27579636
Am J Phys Med Rehabil. 2010 Apr;89(4):304-14
pubmed: 20134307
Neurourol Urodyn. 2011 Sep;30(7):1319-24
pubmed: 21563210
Neurourol Urodyn. 2011 Jan;30(1):47-51
pubmed: 21181960
Int Urogynecol J. 2011 Aug;22(8):923-32
pubmed: 21455757
Int Urogynecol J. 2014 Jul;25(7):883-91
pubmed: 24500453
Am J Obstet Gynecol. 2003 Jul;189(1):98-101
pubmed: 12861145
Int Urogynecol J. 2014 Oct;25(10):1303-12
pubmed: 25091925
Can Urol Assoc J. 2017 Jun;11(6Suppl2):S121-S124
pubmed: 28616109
Neurourol Urodyn. 2010;29(1):213-40
pubmed: 20025020
Int Urogynecol J Pelvic Floor Dysfunct. 2008 Oct;19(10):1359-62
pubmed: 18491026

Auteurs

Vivian W Sung (VW)

The Division of Urogynecology and Reconstructive Pelvic Surgery, Department of Obstetrics and Gynecology, Alpert Medical School of Brown University, Providence, Rhode Island.

Diane Borello-France (D)

Department of Physical Therapy, Rangos School of Health Sciences, Duquesne University, Pittsburgh, Pennsylvania.

Diane K Newman (DK)

The Division of Urology, Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia.

Holly E Richter (HE)

Division of Urogynecology and Pelvic Reconstructive Surgery, Department of Obstetrics and Gynecology, University of Alabama at Birmingham.

Emily S Lukacz (ES)

The Division of Female Pelvic Medicine & Reconstructive Surgery, Department of Obstetrics, Gynecology & Reproductive Sciences, University of California San Diego, La Jolla.

Pamela Moalli (P)

Women's Center for Bladder and Pelvic Health, Division of Urogynecology and Reconstructive Pelvic Surgery, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.

Alison C Weidner (AC)

Division of Urogynecology, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina.

Ariana L Smith (AL)

The Division of Urology, Department of Surgery, Perelman School of Medicine, University of Pennsylvania Health System, Philadelphia.

Gena Dunivan (G)

The Division of Urogynecology, Department of Obstetrics and Gynecology, University of New Mexico, Albuquerque.

Beri Ridgeway (B)

Center for Urogynecology and Reconstructive Pelvic Surgery, Obstetrics, Gynecology and Women's Health Institute, Cleveland Clinic, Cleveland, Ohio.

John N Nguyen (JN)

The Division of Female Pelvic Medicine & Reconstructive Surgery, Department of Obstetrics & Gynecology, Kaiser Permanente, Downey, California.

Donna Mazloomdoost (D)

Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland.

Benjamin Carper (B)

Social, Statistical, & Environmental Sciences, RTI International, Research Triangle Park, North Carolina.

Marie G Gantz (MG)

Social, Statistical, & Environmental Sciences, RTI International, Research Triangle Park, North Carolina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH